FR2891828B1 - Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique - Google Patents
Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutiqueInfo
- Publication number
- FR2891828B1 FR2891828B1 FR0510408A FR0510408A FR2891828B1 FR 2891828 B1 FR2891828 B1 FR 2891828B1 FR 0510408 A FR0510408 A FR 0510408A FR 0510408 A FR0510408 A FR 0510408A FR 2891828 B1 FR2891828 B1 FR 2891828B1
- Authority
- FR
- France
- Prior art keywords
- phtalazine
- derivatives
- amino
- substituted
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0510408A FR2891828B1 (fr) | 2005-10-12 | 2005-10-12 | Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique |
PE2006001223A PE20070550A1 (es) | 2005-10-12 | 2006-10-06 | Derivados de la 1-amino-ftalazina sustituida afines al receptor mch1 y su preparacion |
PCT/FR2006/002271 WO2007042660A2 (fr) | 2005-10-12 | 2006-10-10 | Dérivés de la 1-amino-phtalazine substituee, leur préparation et leur application en thérapeutique |
EP06820177A EP1940823A2 (fr) | 2005-10-12 | 2006-10-10 | Dérivés de la 1-amino-phtalazine substituee, leur préparation et leur application en thérapeutique |
JP2008535059A JP2009511552A (ja) | 2005-10-12 | 2006-10-10 | 置換1−アミノ−フタラジン誘導体、これらの調製およびこれらの治療的使用 |
ARP060104456A AR057980A1 (es) | 2005-10-12 | 2006-10-11 | Derivados de la 1- amino-ftalazina sustituida, su preparacion y composicion farmaceutica |
GT200600455A GT200600455A (es) | 2005-10-12 | 2006-10-11 | Derivados de la 1-amino-ftalazina sustituida, su preparación y su aplicación en terapéutica |
TW095137577A TW200800208A (en) | 2005-10-12 | 2006-10-12 | 1-Aminophthalazine derivatives, preparation thereof and therapeutic application thereof |
DO2006000217A DOP2006000217A (es) | 2005-10-12 | 2006-10-12 | Derivados de la 1-amino-ftalazina sustituida, su preparación y su aplicación en terapéutica |
US12/098,635 US20090124624A1 (en) | 2005-10-12 | 2008-04-07 | Substituted 1-aminophthalazine derivatives, preparation thereof and therapeutic application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0510408A FR2891828B1 (fr) | 2005-10-12 | 2005-10-12 | Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2891828A1 FR2891828A1 (fr) | 2007-04-13 |
FR2891828B1 true FR2891828B1 (fr) | 2007-12-21 |
Family
ID=36623451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0510408A Expired - Fee Related FR2891828B1 (fr) | 2005-10-12 | 2005-10-12 | Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090124624A1 (fr) |
EP (1) | EP1940823A2 (fr) |
JP (1) | JP2009511552A (fr) |
AR (1) | AR057980A1 (fr) |
DO (1) | DOP2006000217A (fr) |
FR (1) | FR2891828B1 (fr) |
GT (1) | GT200600455A (fr) |
PE (1) | PE20070550A1 (fr) |
TW (1) | TW200800208A (fr) |
WO (1) | WO2007042660A2 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090099175A1 (en) * | 2006-03-01 | 2009-04-16 | Arrington Mark P | Phosphodiesterase 10 inhibitors |
CA2666193A1 (fr) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Imidazolidin-2,4-dione arylaminoaryl-alkyl-substituee, son procede de fabrication, medicament contenant ce compose et son utilisation |
WO2010003624A2 (fr) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Composés hétérocycliques, leurs procédés de préparation, médicaments comprenant lesdits composés et leur utilisation |
WO2010068601A1 (fr) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant |
DK2470552T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi Sa | NOVEL, CRYSTALLINE, heteroaromatic FLUORGLYCOSIDHYDRATER, MEDICINES COVERING THESE COMPOUNDS AND THEIR USE |
WO2012120052A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683705B1 (fr) | 2011-03-08 | 2015-04-22 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
WO2012120056A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
EP2683699B1 (fr) | 2011-03-08 | 2015-06-24 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
WO2016123796A1 (fr) * | 2015-02-06 | 2016-08-11 | Abbvie Inc. | Phtalazines substituées |
CN115433163A (zh) * | 2021-06-05 | 2022-12-06 | 药捷安康(南京)科技股份有限公司 | Nlrp3炎症小体抑制剂及其应用 |
CN115417856A (zh) * | 2021-09-30 | 2022-12-02 | 成都奥睿药业有限公司 | 一类取代杂芳酞嗪衍生物的药学用途及其制备方法 |
US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001226269A (ja) * | 2000-02-18 | 2001-08-21 | Takeda Chem Ind Ltd | メラニン凝集ホルモン拮抗剤 |
WO2003070244A1 (fr) * | 2002-02-22 | 2003-08-28 | Abbott Laboratories | Antagoniste des effets d'une hormone de concentration de melanine et son utilisation |
WO2003106452A2 (fr) * | 2002-06-12 | 2003-12-24 | Millennium Pharmaceuticals, Inc. | Antagonistes du recepteur de l'hormone de melano-concentration |
US20060111357A1 (en) * | 2002-12-11 | 2006-05-25 | Frimurer Thomas M | Quinoline compounds for use in mch receptor related disorders |
US7605176B2 (en) * | 2004-03-06 | 2009-10-20 | Boehringer Ingelheim International Gmbh | β-ketoamide compounds with MCH antagonistic activity |
FR2868780B1 (fr) * | 2004-04-13 | 2008-10-17 | Sanofi Synthelabo | Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique |
CN1980674B (zh) * | 2004-06-30 | 2011-05-25 | 詹森药业有限公司 | 作为parp抑制剂的2,3-二氮杂萘衍生物 |
-
2005
- 2005-10-12 FR FR0510408A patent/FR2891828B1/fr not_active Expired - Fee Related
-
2006
- 2006-10-06 PE PE2006001223A patent/PE20070550A1/es not_active Application Discontinuation
- 2006-10-10 EP EP06820177A patent/EP1940823A2/fr not_active Withdrawn
- 2006-10-10 JP JP2008535059A patent/JP2009511552A/ja active Pending
- 2006-10-10 WO PCT/FR2006/002271 patent/WO2007042660A2/fr active Application Filing
- 2006-10-11 GT GT200600455A patent/GT200600455A/es unknown
- 2006-10-11 AR ARP060104456A patent/AR057980A1/es not_active Application Discontinuation
- 2006-10-12 TW TW095137577A patent/TW200800208A/zh unknown
- 2006-10-12 DO DO2006000217A patent/DOP2006000217A/es unknown
-
2008
- 2008-04-07 US US12/098,635 patent/US20090124624A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090124624A1 (en) | 2009-05-14 |
PE20070550A1 (es) | 2007-06-19 |
EP1940823A2 (fr) | 2008-07-09 |
DOP2006000217A (es) | 2007-05-15 |
FR2891828A1 (fr) | 2007-04-13 |
WO2007042660A2 (fr) | 2007-04-19 |
JP2009511552A (ja) | 2009-03-19 |
WO2007042660A3 (fr) | 2007-05-31 |
TW200800208A (en) | 2008-01-01 |
AR057980A1 (es) | 2008-01-09 |
GT200600455A (es) | 2007-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA28575B1 (fr) | Derives de la 1-amino-phthalazine, leur preparation , et leur application en therapeutique | |
FR2891828B1 (fr) | Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique | |
MA28734B1 (fr) | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique | |
FR2882054B1 (fr) | Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique | |
MA28343A1 (fr) | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique | |
FR2911604B1 (fr) | Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique | |
FR2906250B1 (fr) | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique | |
FR2854158B1 (fr) | Derives de 2-acylamino-4-phenylethiazole, leur preparation et leur application en therapeutique | |
MA29017B1 (fr) | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique | |
FR2864080B1 (fr) | Derives de 1-piperazine-et-1-homopiperazine-carboxylates, leur preparation et leur application en therapeutique | |
FR2910473B1 (fr) | Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique. | |
FR2903985B1 (fr) | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique | |
FR2854633B1 (fr) | Derives de piperidinyl-et piperazinyl-alkylcarbamates, leur preparation et leur application en therapeutique | |
FR2888847B1 (fr) | Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique | |
FR2866888B1 (fr) | Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en therapeutique | |
FR2915199B1 (fr) | Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique. | |
FR2880625B1 (fr) | Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique | |
FR2899586B1 (fr) | Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique | |
FR2891825B1 (fr) | Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique | |
FR2917412B1 (fr) | Derives de 7-alkynyl, 1,8-naphthyridones, leur preparation et leur application en therapeutique | |
FR2856684B1 (fr) | Derives de diphenylpyridine, leur preparation et leur application en therapeutique | |
FR2866885B1 (fr) | Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique | |
FR2888848B1 (fr) | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
FR2920023B1 (fr) | Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique | |
FR2917413B1 (fr) | Derives de 7-alkynyl-1,8-naphthyridones, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20090630 |